BERTOLINI, STEFANO
 Distribuzione geografica
Continente #
EU - Europa 15.781
AS - Asia 1.527
NA - Nord America 1.062
Continente sconosciuto - Info sul continente non disponibili 133
SA - Sud America 126
AF - Africa 29
OC - Oceania 1
Totale 18.659
Nazione #
IT - Italia 15.540
US - Stati Uniti d'America 974
SG - Singapore 631
CN - Cina 393
VN - Vietnam 219
BD - Bangladesh 129
FR - Francia 128
BR - Brasile 74
HK - Hong Kong 48
CA - Canada 31
AR - Argentina 23
FI - Finlandia 23
MX - Messico 21
JP - Giappone 17
CH - Svizzera 14
DE - Germania 14
IQ - Iraq 14
IN - India 13
GB - Regno Unito 12
TH - Thailandia 9
CO - Colombia 8
CR - Costa Rica 8
ID - Indonesia 8
SA - Arabia Saudita 7
CL - Cile 6
JM - Giamaica 6
NL - Olanda 6
RU - Federazione Russa 6
UA - Ucraina 6
ZA - Sudafrica 6
ES - Italia 5
GT - Guatemala 5
PE - Perù 5
IE - Irlanda 4
PH - Filippine 4
PK - Pakistan 4
PL - Polonia 4
TR - Turchia 4
VE - Venezuela 4
DZ - Algeria 3
EC - Ecuador 3
HN - Honduras 3
KR - Corea 3
MY - Malesia 3
NI - Nicaragua 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
TW - Taiwan 3
AT - Austria 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CZ - Repubblica Ceca 2
EG - Egitto 2
KE - Kenya 2
LC - Santa Lucia 2
MA - Marocco 2
PR - Porto Rico 2
QA - Qatar 2
RO - Romania 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BJ - Benin 1
BY - Bielorussia 1
CM - Camerun 1
CY - Cipro 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GH - Ghana 1
GP - Guadalupe 1
GR - Grecia 1
IL - Israele 1
IR - Iran 1
JO - Giordania 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
MG - Madagascar 1
ML - Mali 1
MN - Mongolia 1
NA - Namibia 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PY - Paraguay 1
SC - Seychelles 1
SE - Svezia 1
SN - Senegal 1
Totale 18.528
Città #
Genova 10.644
Genoa 2.814
Rapallo 1.131
Vado Ligure 860
Singapore 278
San Jose 214
Lauterbourg 122
Ashburn 120
Hanoi 62
New York 62
Ho Chi Minh City 54
Beijing 52
Santa Clara 45
Hong Kong 39
Helsinki 23
Los Angeles 23
Buffalo 17
Chicago 16
Phoenix 16
Tokyo 16
Council Bluffs 14
Zurich 14
Mexico City 13
Frankfurt am Main 12
Bordighera 11
Dallas 11
Atlanta 9
Haiphong 9
Rome 9
Tianjin 8
Boardman 7
Washington 7
Toronto 6
City of London 5
Da Nang 5
Jacksonville 5
Milan 5
Orem 5
San José 5
São Paulo 5
Alexandria 4
Amsterdam 4
Bangkok 4
Brooklyn 4
Des Moines 4
Dublin 4
East Brunswick 4
Federal Way 4
Houston 4
Miami 4
Milwaukee 4
Monroe 4
Montreal 4
New Delhi 4
Pescara 4
Quảng Ngãi 4
Riyadh 4
San Diego 4
Bogotá 3
Can Tho 3
Columbus 3
Detroit 3
El Paso 3
Florence 3
Garland 3
Guatemala City 3
Ha Long 3
Hagerstown 3
Hangzhou 3
Hải Dương 3
Johannesburg 3
Kingston 3
Lake Ariel 3
London 3
Louisville 3
Managua 3
Memphis 3
Mesa 3
Monte Grande 3
Moscow 3
Nha Trang 3
Philadelphia 3
Rio de Janeiro 3
Santiago 3
Seattle 3
Shanghai 3
Springfield 3
Thái Bình 3
Alachua 2
Alameda 2
Alpharetta 2
Ankara 2
Antakya 2
Azusa 2
Baghdad 2
Baku 2
Birmingham 2
Bologna 2
Bratislava 2
Bảo Lộc 2
Totale 16.959
Nome #
Baseline hs-CRP predicts hypertension remission in metabolic syndrome 228
Lipoproteins, stroke and statins. 219
A complex phenotype in a child with familial HDL deficiency due to a novel frameshift mutation in APOA1 gene (apoA-IGuastalla) 215
Spectrum of mutations of the LPL gene identified in Italy in patients with severe hypertriglyceridemia 214
Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia 192
Effect of ezetimibe coadministered with statins in genotype-confirmed heterozygous FH patients. 191
A three month-old infant with severe hyperchylomicronemia: molecular diagnosis and extracorporeal treatment. 187
A “de novo” mutation of the LDL-receptor gene as the cause of familial hypercholesterolemia. 186
A silent mutation of Niemann-Pick C1-like 1 and apolipoprotein E4 modulate cholesterol absorption in primary hyperlipidemias. 183
A point mutation in ABC1 gene in a patient with severe premature coronary heart disease and mild clinical phenotype of Tangier disease 179
Cholesteryl Ester Storage Disease (CESD) due to novel mutations in the LIPA gene. 177
A novel mutation of the apolipoprotein A-I gene in a family with familial combined hyperlipidemia 175
A study of fatty liver disease and plasma lipoproteins in a kindred with Familial Hypobeta-lipoproteinemia due to a novel truncated form of apolipoprotein B (Apo B 54.5). 174
Genetic polymorphisms affecting the phenotypic expression in familial hypercholesterolemia 171
Autosomal recessive hypercholesterolemia (ARH) and homozygous familial hypercholesterolemia (FH): a phenotypic comparison. 171
A Third Major Locus for Autosomal Dominant Hypercholesterolemia maps at 1p34.1-p32. 171
An apparent inconsistency in parent to offspring transmission of point mutations of LDLR gene in familial hypercholesterolemia. 169
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 169
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features 169
Traditional and non traditional risk factors in accelerated atherosclerosis in systemic lupus erythematosus: role of vascular endothelial growth factor (VEGATS Study). 168
Timely diagnosis of sitosterolemia by next generation sequencing in two children with severe hypercholesterolemia 165
A novel sequence variant in APOA5 gene found in patients with severe hypertriglyceridemia. 164
Abnormal splicing of ABCA1 pre-mRNA in Tangier disease due to a IVS2 +5G>C mutation in ABCA1 gene 163
Mutations in MTP gene in abeta- and hypobeta-lipoproteinemia. 162
A 33-year-old man with nephrotic syndrome and lecithin-cholesterol acyltransferase (LCAT) deficiency. Description of two new mutations in the LCAT gene 161
Lysosomal lipase deficiency: Molecular characterization of eleven patients with Wolman or cholesteryl ester storage disease. 161
A new missense mutation (Cys297-->Phe) of the low density lipoprotein receptor in Italian patients with familial hypercholesterolemia (FHTrieste). 160
Multiple abnormally spliced ABCA1 mRNAs caused by a novel splice site mutation of ABCA1 gene in a patient with Tangier disease. 159
HEMORHEOLOGICAL AND CEREBRAL BLOOD FLOW CHANGES INDUCED BY LDL- APHERESIS IN FAMILIAL HYPERCHOLESTEROLEMIC PATIENTS. 159
Familial HDL deficiency due to ABCA1 gene mutations with or without other genetic lipoprotein disorders. 158
A ‘de novo’ point mutation of the low-density lipoprotein receptor gene in an Italian subject with primary hypercholesterolemia 158
Four novel partial deletions of LDL receptor gene in Italian patients with Familial Hypercholesterolemia 155
Spectrum of mutations and phenotypic expression in patients with autosomal dominant hypercholesterolemia identified in Italy. 155
Regional cerebral blood flow in familial hypercholesterolemia 155
Use of three DNA polymorphisms of the LDL-receptor gene in the diagnosis of Familial Hypercholesterolemia. 154
Long term substrate reduction therapy with ezetimibe alone or associated with statins in three adult patients with lysosomal acid lipase deficiency 154
Analysis of LDL receptor gene mutations in Italian patients with homozygous Familial Hypercholesterolemia 153
Severe HDL deficiency due to novel defects in the ABCA1 transporter. 152
Heterozygosity for lysosomal acid lipase E8SJM mutation and serum lipid concentrations. 152
Pseudodominance of lipoprotein lipase (LPL) deficiency due to a nonsense mutation (Tyr302>Term) in exon 6 of LPL gene in an Italian family from Sardinia (LPL Olbia). 151
Duplication of exons 13, 14 and 15 of LDL-receptor gene in a patient with heterozygous Familial Hypercholesterolemia. 150
Presence of soluble amyloid beta peptide precedes amyloid plaque formation in Down's syndrome 149
The type of LDLR gene mutation predicts cardiovascular risk in children with familial hypercholesterolemia 148
Identification of an alternative transcript of ABCA1 gene in different human cell types. 147
Chorionic DNA analysis for the prenatal diagnosis of familial hypercholesterolemia. 146
Correlation between Progetto Cuore risk score and early cardiovascular damage in never treated subjects 146
Quantitative polymerase chain reaction and microchip electrophoresis to detect major rearrangements of the low-density lipoprotein receptor gene causing familial hypercholesterolemia. 146
Lipoprotein glomerulopathy associated with a mutation in apolipoprotein e. 145
Altered mRNA splicing in lipoprotein disorders. 145
Novel mutations of ABCA1 transporter in patients with Tangier disease and familial HDL deficiency. 144
Therapeutic management of a new case of LCAT deficiency with a multifactorial long-term approach based on high doses of angiotensin II receptor blockers (ARBs) 144
Serum lipoprotein (a) predicts acute coronary syndromes in patients with severe carotid stenosis 144
Serum homocysteine, methylenetetrahydrofolate reductase gene polymorphism and cardiovascular disease in heterozygous familial hypercholesterolemia. 142
Cerebrotendinous xanthomatosis caused by two new mutations of sterol-27-hydroxylase gene that disrupt mRNA splicing. 142
Pseudoxanthoma elasticum and familial hypercholesterolemia: A deleterious combination of cardiovascular risk factors 140
Pvu II polymorphism of low density lipoprotein receptor gene and familial hypercholesterolemia. Study of Italians. 139
Blood and synovial levels of piroxicam and their effects on some metabolites of arachidonic acid 138
Physical activity modulates effects of some genetic polymorphisms affecting cardiovascular risk in men aged over 40 years. 138
Two Italian Kindreds Carrying the Arg136>Ser Mutation of Apo E Gene: Development of Premature and Severe Atherosclerosis in the presence of Epsilon 2 as Second Allele 137
Gene polymorphisms predicting high plasma levels of coagulation and fibrinolysis proteins: a study in centenarians. 136
Leucine 10 allelic variant in signal peptide of PCSK9 increases the LDL cholesterol-lowering effect of statins in patients with familial hypercholesterolaemia. 135
LDL apheresis in a homozygous familial hypercholesterolemic child aged 4.5. 135
p53 variants predisposing to cancer are present in healthy centenarians. 133
Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels and sterol elimination: implications for classification and disease risk 133
Italian familial defective apolipoprotein B patients share a unique haplotype with other Caucasian patients. 132
Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL Receptor Adaptor Protein. 132
Polymorphisms of Drug-Metabolizing Enzymes in healthy Nonagenarians and Centenarians: difference at GSTT1 locus. 132
Recurrent mutations of the apolipoprotein A-I gene in three kindreds with severe HDL deficiency. 132
Paradoxes in longevity: sequence analysis of mtDNA haplogroup J in centenarians. 131
Combined monogenic hypercholesterolemia and hypoalphalipoproteinemia caused by mutations in LDL-R and LCAT genes 131
Hypocomplementemic type II membranoproliferative glomerulonephritis in a male patient with familial lecithin-cholesterol acyltransferase deficiency due to two different allelic mutations. 131
A large deletion in the LDL-receptor gene. The cause of Familial Hypercholesterolemia in three italian families: a study that dates back to the 17th century (FH Pavia). 130
Alternative splicing of mutant LDL-receptor mRNA in an Italian patient with familial hypercholesterolemia due to a partial deletion of LDL-receptor gene (FH Potenza). 130
Partial duplication of the EGF precursor homology domain of the LDL-receptor protein causing Familial Hypercholesterolemia (FH Salerno) 129
Functional analysis of the promoter of human sterol 27-hydroxylase gene in HepG2 cells. 128
Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia. 128
Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis. 128
Effects of a phytosterol-enriched dairy product on lipids, sterols and 8-isoprostane in hypercholesterolemic patients: a multicenter Italian study. 127
Analysis of two duplications of the LDL receptor gene affecting intracellular transport, catabolism, and surface binding of the LDL receptor. 127
Abnormal apolipoprotein B pre-mRNA splicing in patients with familial hypobetalipoproteinemia. 126
Functional analysis of two novel splice site mutations of APOB gene in familial hypobetalipoproteinemia. 125
Molecular characterization of two patients with severe LCAT deficiency. 125
Mitochondrial DNA inherited variants are associated with successful aging and longevity in humans. 125
Characterization of three mutations of LDL-receptor gene in Italians patients with Familial Hypercholesterolemia. 124
Efficacy and safety of atorvastatin compared to pravastatin in patients with hypercholesterolemia. 123
Effects of three low-dose oral contraceptive formulations on lipid metabolism. 123
Severe hypertriglyceridemia in a newborn with monogenic lipoprotein lipase deficiency: an unconventional therapeutic approach with exchange transfusion. 123
Hypobetalipoproteinemia with an apparently recessive inheritance due to a “de novo” mutation of apolipoprotein B. 122
Low-density lipoprotein apheresis in a patient aged 3.5 years. 121
Influence of beta(0)-thalassemia on the phenotypic expression of heterozygous familial hypercholesterolemia : a study of patients with familial hypercholesterolemia from Sardinia. 119
Occurrence of multiple aberrantly spliced mRNAs of LDL-receptor Gene upon a donor splice site mutation that causes Familial Hypercholesterolemia (FH-Benevento). 119
Four novel mutations of sterol-27-hydroxylase gene in Italian patients with cerebrotendinous xanthomatosis. 118
Denaturing high-performance liquid chromatography (DHPLC) in the detection of mutations of ABCA1 gene in Familial HDL Deficiency. 118
Mutant factor V (Arg506Gln) in healthy centenarians. 118
DNA multiallelic systems reveal gene/longevity associations not detected by diallelic systems. The APOB locus. 118
APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency. 117
Variation in the LDL-receptor gene is associated with differences in plasma LDL-cholesterol levels in young and old normal individuals from Italy. 116
Pharmacological treatment of a Sardinian patient affected by autosomal recessive hypercholesterolemia (ARH) 115
Adaptor protein ARH is recruited to the plasma membrane by LDL binding and modulates endocytosis of the LDL/LDLR complex in hepatocytes. 114
Two novel partial deletions of LDL-receptor gene in Italian patients with familial hypercholesterolemia (FH Siracusa and FH Reggio Emilia). 114
Totale 14.732
Categoria #
all - tutte 54.217
article - articoli 54.217
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.434


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.599 54 126 105 222 34 136 117 367 65 135 63 175
2022/20231.385 148 62 30 124 264 300 3 103 241 5 92 13
2023/2024643 30 103 12 84 85 135 22 20 29 5 40 78
2024/20251.900 36 165 73 137 305 197 139 278 46 87 167 270
2025/20263.537 402 109 194 276 482 388 576 166 241 298 263 142
2026/2027442 442 0 0 0 0 0 0 0 0 0 0 0
Totale 18.659